Long-Term Aspirin Use Reduces Colorectal Cancer Risk – Nurses’ Health Study
This article was originally published in The Tan Sheet
Executive Summary
Women who took more than 14 aspirin per week for 10 years or more demonstrated a 33% lower risk for colorectal cancer compared to nonusers, according to a study published in the Aug. 24-31 Journal of the American Medical Association
You may also be interested in...
Aspirin, NSAID Risks Outweigh Colon Cancer Benefits – AHRQ Task Force
A panel of prevention and primary care experts sponsored by the Agency for Healthcare Research and Quality is recommending against the use of aspirin and non-steroidal anti-inflammatory drugs for primary prevention of colorectal cancer
Aspirin Colorectal Adenoma Risk Significantly Reduced, NEJM Studies Find
Daily aspirin therapy reduces the incidence of recurrent adenomas among colorectal cancer survivors and individuals with a history of adenomas, according to two separate studies in the March 6 New England Journal of Medicine
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC